Closure of a recurrent bronchopleural fistula using a matrix seeded with patient-derived mesenchymal stem cells

Johnathon M. Aho, Allan B Dietz, Darcie J. Radel, Greg W. Butler, Mathew Thomas, Timothy J Nelson, Brian T. Carlsen, Stephen D. Cassivi, Zachary T. Resch, William Alvis Faubion, Dennis A Wigle

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Management of recurrent bronchopleural fistula (BPF) after pneumonectomy remains a challenge. Although a variety of devices and techniques have been described, definitive management usually involves closure of the fistula tract through surgical intervention. Standard surgical approaches for BPF incur significant morbidity and mortality and are not reliably or uniformly successful. We describe the first-in-human application of an autologousmesenchymal stemcell (MSC)-seededmatrix graft to repair amultiply recurrent postpneumonectomy BPF. Adipose-derivedMSCs were isolated from patient abdominal adipose tissue, expanded, and seeded onto bio-absorbable mesh, which was surgically implanted at the site of BPF. Clinical follow-up and postprocedural radiological and bronchoscopic imaging were performed to ensure BPF closure, and in vitro stemness characterization of patient-specific MSCs was performed. The patient remained clinically asymptomatic without evidence of recurrence on bronchoscopy at 3months, computed tomographic imaging at 16 months, and clinical follow-up of 1.5 years. There is no evidence ofmalignant degeneration ofMSC populations in situ, and the patient-derived MSCs were capable of differentiating into adipocytes, chondrocytes, and osteocytes using established protocols. Isolation and expansion of autologous MSCs derived from patients in a malnourished, deconditioned state is possible. Successful closure and safety data for this approach suggest the potential for an expanded study of the role of autologous MSCs in regenerative surgical applications for BPF.

Original languageEnglish (US)
Pages (from-to)1375-1379
Number of pages5
JournalStem cells translational medicine
Volume5
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Mesenchymal Stromal Cells
Fistula
Osteocytes
Abdominal Fat
Pneumonectomy
Bronchoscopy
Chondrocytes
Adipocytes
Morbidity
Transplants
Safety
Recurrence
Equipment and Supplies
Mortality
Population

Keywords

  • Bronchopleural fistula
  • Cell transplantation
  • Cellular therapy
  • Clinical translation
  • Mesenchymal stem cells
  • Stem cell transplantation

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Closure of a recurrent bronchopleural fistula using a matrix seeded with patient-derived mesenchymal stem cells. / Aho, Johnathon M.; Dietz, Allan B; Radel, Darcie J.; Butler, Greg W.; Thomas, Mathew; Nelson, Timothy J; Carlsen, Brian T.; Cassivi, Stephen D.; Resch, Zachary T.; Faubion, William Alvis; Wigle, Dennis A.

In: Stem cells translational medicine, Vol. 5, No. 10, 01.10.2016, p. 1375-1379.

Research output: Contribution to journalArticle

Aho, Johnathon M. ; Dietz, Allan B ; Radel, Darcie J. ; Butler, Greg W. ; Thomas, Mathew ; Nelson, Timothy J ; Carlsen, Brian T. ; Cassivi, Stephen D. ; Resch, Zachary T. ; Faubion, William Alvis ; Wigle, Dennis A. / Closure of a recurrent bronchopleural fistula using a matrix seeded with patient-derived mesenchymal stem cells. In: Stem cells translational medicine. 2016 ; Vol. 5, No. 10. pp. 1375-1379.
@article{28fd2080d92644139e23b3c45af3f733,
title = "Closure of a recurrent bronchopleural fistula using a matrix seeded with patient-derived mesenchymal stem cells",
abstract = "Management of recurrent bronchopleural fistula (BPF) after pneumonectomy remains a challenge. Although a variety of devices and techniques have been described, definitive management usually involves closure of the fistula tract through surgical intervention. Standard surgical approaches for BPF incur significant morbidity and mortality and are not reliably or uniformly successful. We describe the first-in-human application of an autologousmesenchymal stemcell (MSC)-seededmatrix graft to repair amultiply recurrent postpneumonectomy BPF. Adipose-derivedMSCs were isolated from patient abdominal adipose tissue, expanded, and seeded onto bio-absorbable mesh, which was surgically implanted at the site of BPF. Clinical follow-up and postprocedural radiological and bronchoscopic imaging were performed to ensure BPF closure, and in vitro stemness characterization of patient-specific MSCs was performed. The patient remained clinically asymptomatic without evidence of recurrence on bronchoscopy at 3months, computed tomographic imaging at 16 months, and clinical follow-up of 1.5 years. There is no evidence ofmalignant degeneration ofMSC populations in situ, and the patient-derived MSCs were capable of differentiating into adipocytes, chondrocytes, and osteocytes using established protocols. Isolation and expansion of autologous MSCs derived from patients in a malnourished, deconditioned state is possible. Successful closure and safety data for this approach suggest the potential for an expanded study of the role of autologous MSCs in regenerative surgical applications for BPF.",
keywords = "Bronchopleural fistula, Cell transplantation, Cellular therapy, Clinical translation, Mesenchymal stem cells, Stem cell transplantation",
author = "Aho, {Johnathon M.} and Dietz, {Allan B} and Radel, {Darcie J.} and Butler, {Greg W.} and Mathew Thomas and Nelson, {Timothy J} and Carlsen, {Brian T.} and Cassivi, {Stephen D.} and Resch, {Zachary T.} and Faubion, {William Alvis} and Wigle, {Dennis A}",
year = "2016",
month = "10",
day = "1",
doi = "10.5966/sctm.2016-0078",
language = "English (US)",
volume = "5",
pages = "1375--1379",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "10",

}

TY - JOUR

T1 - Closure of a recurrent bronchopleural fistula using a matrix seeded with patient-derived mesenchymal stem cells

AU - Aho, Johnathon M.

AU - Dietz, Allan B

AU - Radel, Darcie J.

AU - Butler, Greg W.

AU - Thomas, Mathew

AU - Nelson, Timothy J

AU - Carlsen, Brian T.

AU - Cassivi, Stephen D.

AU - Resch, Zachary T.

AU - Faubion, William Alvis

AU - Wigle, Dennis A

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Management of recurrent bronchopleural fistula (BPF) after pneumonectomy remains a challenge. Although a variety of devices and techniques have been described, definitive management usually involves closure of the fistula tract through surgical intervention. Standard surgical approaches for BPF incur significant morbidity and mortality and are not reliably or uniformly successful. We describe the first-in-human application of an autologousmesenchymal stemcell (MSC)-seededmatrix graft to repair amultiply recurrent postpneumonectomy BPF. Adipose-derivedMSCs were isolated from patient abdominal adipose tissue, expanded, and seeded onto bio-absorbable mesh, which was surgically implanted at the site of BPF. Clinical follow-up and postprocedural radiological and bronchoscopic imaging were performed to ensure BPF closure, and in vitro stemness characterization of patient-specific MSCs was performed. The patient remained clinically asymptomatic without evidence of recurrence on bronchoscopy at 3months, computed tomographic imaging at 16 months, and clinical follow-up of 1.5 years. There is no evidence ofmalignant degeneration ofMSC populations in situ, and the patient-derived MSCs were capable of differentiating into adipocytes, chondrocytes, and osteocytes using established protocols. Isolation and expansion of autologous MSCs derived from patients in a malnourished, deconditioned state is possible. Successful closure and safety data for this approach suggest the potential for an expanded study of the role of autologous MSCs in regenerative surgical applications for BPF.

AB - Management of recurrent bronchopleural fistula (BPF) after pneumonectomy remains a challenge. Although a variety of devices and techniques have been described, definitive management usually involves closure of the fistula tract through surgical intervention. Standard surgical approaches for BPF incur significant morbidity and mortality and are not reliably or uniformly successful. We describe the first-in-human application of an autologousmesenchymal stemcell (MSC)-seededmatrix graft to repair amultiply recurrent postpneumonectomy BPF. Adipose-derivedMSCs were isolated from patient abdominal adipose tissue, expanded, and seeded onto bio-absorbable mesh, which was surgically implanted at the site of BPF. Clinical follow-up and postprocedural radiological and bronchoscopic imaging were performed to ensure BPF closure, and in vitro stemness characterization of patient-specific MSCs was performed. The patient remained clinically asymptomatic without evidence of recurrence on bronchoscopy at 3months, computed tomographic imaging at 16 months, and clinical follow-up of 1.5 years. There is no evidence ofmalignant degeneration ofMSC populations in situ, and the patient-derived MSCs were capable of differentiating into adipocytes, chondrocytes, and osteocytes using established protocols. Isolation and expansion of autologous MSCs derived from patients in a malnourished, deconditioned state is possible. Successful closure and safety data for this approach suggest the potential for an expanded study of the role of autologous MSCs in regenerative surgical applications for BPF.

KW - Bronchopleural fistula

KW - Cell transplantation

KW - Cellular therapy

KW - Clinical translation

KW - Mesenchymal stem cells

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=84988622221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988622221&partnerID=8YFLogxK

U2 - 10.5966/sctm.2016-0078

DO - 10.5966/sctm.2016-0078

M3 - Article

VL - 5

SP - 1375

EP - 1379

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 10

ER -